75 related articles for article (PubMed ID: 9207252)
1. Should DCC be deleted as tumor-suppressor candidate?
Gastroenterology; 1997 Jul; 113(1):3. PubMed ID: 9207252
[No Abstract] [Full Text] [Related]
2. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
3. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients.
Kubo H; Miki C; Kusunoki M
Hepatogastroenterology; 2004; 51(55):114-7. PubMed ID: 15011843
[TBL] [Abstract][Full Text] [Related]
5. [DCC changes and prognosis in colorectal carcinoma].
Fiocca R
Pathologica; 1998 Feb; 90(1):79-80. PubMed ID: 9628983
[No Abstract] [Full Text] [Related]
6. Role of the dependence receptor DCC in colorectal cancer pathogenesis.
Mehlen P; Fearon ER
J Clin Oncol; 2004 Aug; 22(16):3420-8. PubMed ID: 15310786
[TBL] [Abstract][Full Text] [Related]
7. DCC: linking tumour suppressor genes and altered cell surface interactions in cancer?
Cho KR; Fearon ER
Eur J Cancer; 1995; 31A(7-8):1055-60. PubMed ID: 7576991
[TBL] [Abstract][Full Text] [Related]
8. DCC expression and prognosis in colorectal cancer.
Banerjee AK
Lancet; 1997 Apr; 349(9057):968. PubMed ID: 9100619
[No Abstract] [Full Text] [Related]
9. Aberration of p53 and DCC in gastric and colorectal cancer.
Kataoka M; Okabayashi T; Johira H; Nakatani S; Nakashima A; Takeda A; Nishizaki M; Orita K; Tanaka N
Oncol Rep; 2000; 7(1):99-103. PubMed ID: 10601600
[TBL] [Abstract][Full Text] [Related]
10. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA
Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594
[TBL] [Abstract][Full Text] [Related]
11. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease.
Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A
Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293
[TBL] [Abstract][Full Text] [Related]
12. [DCC, come back of a suppressor gene in colorectal cancer].
Broutier L; Castets M
Med Sci (Paris); 2012 May; 28(5):465-8. PubMed ID: 22642996
[No Abstract] [Full Text] [Related]
13. No SMAD4 hypermethylation in colorectal cancer.
Roth S; Laiho P; Salovaara R; Launonen V; Aaltonen LA
Br J Cancer; 2000 Oct; 83(8):1015-9. PubMed ID: 10993648
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis and G2/M cell cycle arrest by DCC.
Chen YQ; Hsieh JT; Yao F; Fang B; Pong RC; Cipriano SC; Krepulat F
Oncogene; 1999 Apr; 18(17):2747-54. PubMed ID: 10348349
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor genes.
Anand A
Hosp Pract (Off Ed); 1993 Jan; 28(1):21. PubMed ID: 8419413
[No Abstract] [Full Text] [Related]
16. [Tumor suppressor genes in cancers of colon and rectum].
Thomas G; Olschwang S; Laurent-Puig P
Rev Prat; 1991 Nov; 41(23):2313-5. PubMed ID: 1792493
[No Abstract] [Full Text] [Related]
17. Infrequent inactivation of DCC gene in replication error-positive colorectal cancers.
Yamamoto H; Itoh F; Kusano M; Yoshida Y; Hinoda Y; Imai K
Biochem Biophys Res Commun; 1998 Mar; 244(1):204-9. PubMed ID: 9514909
[TBL] [Abstract][Full Text] [Related]
18. A comparative microsatellite analysis of colorectal cancer in patients <35 years and >50 years of age.
Naidoo R; Tarin M; Chetty R
Am J Gastroenterol; 2000 Nov; 95(11):3266-75. PubMed ID: 11095352
[TBL] [Abstract][Full Text] [Related]
19. Low expression of reduced folate carrier-1 and folylpolyglutamate synthase correlates with lack of a deleted in colorectal carcinoma mRNA splice variant in normal-appearing mucosa of colorectal carcinoma patients.
Wettergren Y; Odin E; Nilsson S; Willen R; Carlsson G; Gustavsson B
Cancer Detect Prev; 2005; 29(4):348-55. PubMed ID: 16122883
[TBL] [Abstract][Full Text] [Related]
20. The deleted in colorectal carcinoma (DCC) gene 201 R --> G polymorphism: no evidence for genetic association with autoimmune disease.
Hall RJ; Merriman ME; Green RA; Markham VH; Smyth DJ; Heward JM; Jennings CE; Braithwaite AW; Cundy T; Darlow BA; Gow PJ; Harrison AA; Highton J; Hunt PJ; Manning P; Pokorny V; Scott RS; Taylor BJ; Willis JA; Yeoman S; McLean L; Gough SC; Pearce SH; Merriman TR
Eur J Hum Genet; 2003 Nov; 11(11):840-4. PubMed ID: 14571268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
